Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Linden Care LLC et al.
Penalty: $9,000,000
Year: 2023
Date: May 4, 2023
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Secondary Offense: qui tam whistleblower lawsuit
Violation Description: In a qui tam whistleblower case in which there was no government intervention, specialty pharmacy Linden Care, associated companies and their private equity owner Belhealth Investment Partners agreed to pay $9 million to settle False Claims Act allegations of unlawfully distributing Subsys, a potent, rapid-onset fentanyl sublingual spray.
Level of Government: federal
Action Type: private litigation
Court: Central District of California
Civil or Criminal Case: civil
Case ID: 2:16-cv-07937
Case Name: United States of America et al v. INSYS Therapeutics, Inc., et al
Private Lawsuit Resolution Type: settlement
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.